DK141055C - Fremgangsmaade til fremstilling af en intravenoest acceptabel vaccine mod hundesyge og hepatitis contagiosa canis - Google Patents

Fremgangsmaade til fremstilling af en intravenoest acceptabel vaccine mod hundesyge og hepatitis contagiosa canis

Info

Publication number
DK141055C
DK141055C DK291173A DK291173A DK141055C DK 141055 C DK141055 C DK 141055C DK 291173 A DK291173 A DK 291173A DK 291173 A DK291173 A DK 291173A DK 141055 C DK141055 C DK 141055C
Authority
DK
Denmark
Prior art keywords
intravenost
contagiosa
canis
hepatitis
preparing
Prior art date
Application number
DK291173A
Other languages
English (en)
Other versions
DK141055B (da
Inventor
O Ackermann
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK141055B publication Critical patent/DK141055B/da
Application granted granted Critical
Publication of DK141055C publication Critical patent/DK141055C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G10—MUSICAL INSTRUMENTS; ACOUSTICS
    • G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L15/00—Speech recognition
    • G10L15/22—Procedures used during a speech recognition process, e.g. man-machine dialogue
    • G10L2015/226—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics
    • G10L2015/227—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics of the speaker; Human-factor methodology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK291173A 1972-05-26 1973-05-25 Fremgangsmaade til fremstilling af en intravenoest acceptabel vaccine mod hundesyge og hepatitis contagiosa canis DK141055C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2225548A DE2225548C3 (de) 1972-05-26 1972-05-26 Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis

Publications (2)

Publication Number Publication Date
DK141055B DK141055B (da) 1979-12-31
DK141055C true DK141055C (da) 1980-06-23

Family

ID=5845894

Family Applications (1)

Application Number Title Priority Date Filing Date
DK291173A DK141055C (da) 1972-05-26 1973-05-25 Fremgangsmaade til fremstilling af en intravenoest acceptabel vaccine mod hundesyge og hepatitis contagiosa canis

Country Status (13)

Country Link
US (1) US3886270A (da)
AR (1) AR201193A1 (da)
AT (1) AT336779B (da)
AU (1) AU467451B2 (da)
BE (1) BE800132A (da)
CA (1) CA1020461A (da)
DE (1) DE2225548C3 (da)
DK (1) DK141055C (da)
FR (1) FR2189023B1 (da)
GB (1) GB1437006A (da)
NL (1) NL163428C (da)
SE (1) SE7608007L (da)
ZA (1) ZA733571B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
US5000951A (en) * 1987-03-09 1991-03-19 Diamond Scientific Company Multivalent canine distemper virus vaccine
CN105884889A (zh) * 2016-04-18 2016-08-24 内蒙古神元生物工程股份有限公司 犬瘟热-传染性肝炎-细小病毒三联卵黄抗体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US3316153A (en) * 1965-03-29 1967-04-25 Lilly Co Eli Virus purification
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
ATA459273A (de) 1976-09-15
DK141055B (da) 1979-12-31
SE7608007L (sv) 1976-07-13
NL163428C (nl) 1980-09-15
AU5612573A (en) 1974-11-28
GB1437006A (en) 1976-05-26
ZA733571B (en) 1974-04-24
DE2225548B2 (de) 1979-09-06
NL163428B (nl) 1980-04-15
CA1020461A (en) 1977-11-08
DE2225548A1 (de) 1973-12-06
FR2189023A1 (da) 1974-01-25
DE2225548C3 (de) 1980-05-29
AU467451B2 (en) 1975-12-04
BE800132A (fr) 1973-11-28
US3886270A (en) 1975-05-27
NL7306986A (da) 1973-11-28
AR201193A1 (es) 1975-02-21
FR2189023B1 (da) 1976-12-03
AT336779B (de) 1977-05-25

Similar Documents

Publication Publication Date Title
DK145283C (da) Vaccine til forhindring af graviditet og fremgangsmaade til fremstilling af vaccinen
NL7706301A (nl) Farmaceutisch inbrengpreparaat en werkwijze ter bereiding daarvan.
SE421997B (sv) Forfarande for framstellning av renat albumin genom termokoagulering
NL7509080A (nl) Farmaceutisch preparaat en werkwijze ter bereiding ervan.
NL7604429A (nl) Werkwijze voor het bereiden van een hepatitis b vaccin.
DK136214C (da) Fremgangsmade til fremstilling af 2-amino-1,4-dihydropyridinderivater
DK132738C (da) Fremgangsmade til fremstilling af orale penicillinpreparater med forbedret smag
NL7704239A (nl) Werkwijze ter bereiding van een paarde-rhino- pneumonie-virus vaccin en aldus verkregen vac- cin.
DK292475A (da) Fremgangsmade til fremstilling af derivater af 3-amino-2-hydroxy-1-phenoxy-propan
DK151628C (da) Analogifremgangsmaade til fremstilling af benzimidazolderivater
IT976898B (it) Elementi imbottiti e procedimento per fabbricarli
DK386875A (da) Fremgangsmade til fremstilling af en vaccine mod tarmsygdomme
DK141055C (da) Fremgangsmaade til fremstilling af en intravenoest acceptabel vaccine mod hundesyge og hepatitis contagiosa canis
DK131864C (da) Fremgangsmade til fremstilling af pregnan-21-syrederivater
IT976334B (it) Fotomaschera e procedimento per ot tenerla
DK135380B (da) Analogifremgangsmade til fremstilling af pregnan-21-syrederivater
DK131890C (da) Fremgangsmade til fremstilling af en tandplejemiddelgel
NL177079C (nl) Werkwijze voor het bereiden van een colibacillosis vaccin.
NL7602413A (nl) Werkwijze voor het bereiden van een vaccin.
DK224175A (da) Tiofenderivater og fremgangsmade til deres fremstilling
DK135944C (da) Fremgangsmade til fremstilling af indolderivater
NL7610657A (nl) Werkwijze voor het bereiden van een vaccin tegen hepatitis a.
DK224275A (da) Tiofenderivater og fremgangsmade til deres fremstilling
DK134303C (da) Fremgangsmade til malkning og malkemaskine til udovelse af fremgangsmaden
DK146312C (da) Fremgangsmaade til fremstilling af en vaccine mod neonatal diarre

Legal Events

Date Code Title Description
PBP Patent lapsed